Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by Stocktreeon Mar 10, 2016 5:24pm
171 Views
Post# 24645577

Hmmm 300 000 at 3:30

Hmmm 300 000 at 3:30Weird dump/purchase of 300,000 shares at 3:30.


No DSMB update.

No word on compassionate program.

No real promotion/communication/education effort.

No Nasdaq.

No price support.

No guarantee anything good will happen to small SH's even in the very likely event of an FDA approval (if the price does not steadily rise at this point, when the treatment gets approved, there's a good chance this stock will be taken from our small hands at a ridiculous price).

Management does not say what the future of the company looks like. Do they want to do something else than distribute their 2 products? Do they want to follow other opportunities? Develop other products. Make acquisitions? 

Best product/opportunity right now. But no word.

There is no other reason for this lame promotion/dilution situation than to let insiders and friends get in at the lowest price possible or to set up a takeover.

I'll go bake my levain bread and learn a foreign language while I wait for some positive/disappointing news.

Have a good weekend!


Bullboard Posts